Multimedia

Latest California Healthline Stories

KHN’s ‘What the Health?’: More Covid Complications for Congress

Congress is back in session, but covid diagnoses for Vice President Kamala Harris and two Democratic senators have temporarily left the Senate without a working majority to approve continued covid funding. Meanwhile, opponents of the Affordable Care Act have filed yet another lawsuit challenging a portion of the law, and we say goodbye to the late Sen. Orrin Hatch of Utah, who left a long legacy of health laws. Rachel Cohrs of STAT News, Anna Edney of Bloomberg News, and Rebecca Adams of KHN join KHN’s Julie Rovner to discuss these issues and more.

KHN’s ‘What the Health?’: A Conversation With Peter Lee on What’s Next for the ACA

Amid covid-19, the potential overturn of Roe v. Wade, and a war in Europe, the Affordable Care Act has been flying under the radar in 2022. But this will be a pivotal year for the federal health law. Unless Congress acts, millions of Americans could see their costs for coverage rise dramatically as expanded subsidies expire. At the same time, the end of the public health emergency could boost the uninsured rate as states disenroll people from Medicaid. Peter Lee, who recently stepped down as the first executive director of the largest state-run ACA insurance marketplace, Covered California, has thought long and hard about how the ACA came to be, how it’s been implemented, and what should happen to it now. He joins host and KHN chief Washington correspondent Julie Rovner for a wide-ranging discussion on the state of the ACA.

How the Test-to-Treat Pillar of the US Covid Strategy Is Failing Patients

The federal “test-to-treat” program was designed to be a one-stop shop for people to get tested for covid and to receive treatment. But as covid cases rise again, many communities have no participating locations, and website bugs make it difficult to book an appointment at the biggest participant.

KHN’s ‘What the Health?’: News You Might Have Missed

Congress is in recess, so the slower-than-average news week gives us a chance to catch up on underreported topics, like Medicare’s coverage decision for the controversial Alzheimer’s disease drug Aduhelm and ominous new statistics on drug overdose deaths and sexually transmitted diseases. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

Persistent Problem: High C-Section Rates Plague the South

Some U.S. states have reduced use of the procedure, including by sharing C-section data with doctors and hospitals. But change has proved difficult in the South, where women are generally less healthy heading into their pregnancies and maternal and infant health problems are among the highest in the U.S.